Search

Your search keyword '"acute infective endocarditis"' showing total 2 results
Start Over Descriptor "acute infective endocarditis" Publisher elsevier
2 results on '"acute infective endocarditis"'

1. Aortic infective endocarditis decompensated by alithiasic cholecystitis in a patient on hemodialysis: Case report

Author

Seydou Harouna Idrissa, Rachida Habbal, Leila Azzouzi, Karim Mounaouir, Imad Nouamou, A. Drighil, and Amadou Baragé

Subjects
medicine.medical_specialty, medicine.drug_class, medicine.medical_treatment, Antibiotics, Case Report, Disease, 03 medical and health sciences, 0302 clinical medicine, medicine, CT Scan, Acute infective endocarditis, Cholecystitis alithiasic, business.industry, General Medicine, medicine.disease, Surgery, Acute Endocarditis, 030220 oncology & carcinogenesis, Infective endocarditis, Hemodialysis, Etiology, Cholecystitis, 030211 gastroenterology & hepatology, business
Abstract

Infective endocarditis is an uncommon disease, which most often affects elderly subjects at risk or with favorable factors. Its prognosis is guarded with complications or decompensating factors that are often formidable. We report the case of an acute endocarditis decompensated by acute alithiasic cholecystitis in a 52-year-old patient, with a history of diagnosed end-stage renal failure (GFR 7 ml/min according to the MDRD) for 4 weeks, of undetermined etiology, undergoing hemodialysis, followed for aortic disease for 6 years (IAO grade II, RAO loose). After 6 weeks, the evolution was favorable under adapted and early antibiotic treatment and associated hygiene measures including gastric rest. Infective endocarditis remains a serious pathology, due to its high morbi-mortality. The association of acute infective endocarditis and acute alithiasic cholecystitis is of reserved prognosis especially on a ground of immunodepression like the end-stage chronic renal failure. This association requires a rapid and efficient management., Highlights - Infectious endocarditis most often affects subjects at risk or with favorable factors - Alithiasis cholecystitis is an acute and necrotic inflammation of the gallbladder, in the absence of gallstones - It can be a decompensating factor of an infective endocarditis - The association of acute infective endocarditis and acute alithiasic cholecystitis is of reserved prognosis and requires a fast and effective management

Published
2021

2. Surgical treatment of isolated tricuspid valve infective endocarditis: 25-year results from a multicenter registry.

Author

Di Mauro M, Foschi M, Dato GMA, Centofanti P, Barili F, Corte AD, Ratta ED, Cugola D, Galletti L, Santini F, Salsano A, Rinaldi M, Mancuso S, Cappabianca G, Beghi C, De Vincentiis C, Biondi A, Livi U, Sponga S, Pacini D, Murana G, Scrofani R, Antona C, Cagnoni G, Nicolini F, Benassi F, De Bonis M, Pozzoli A, Casali G, Scrascia G, Falcetta G, Bortolotti U, Musumeci F, Gherli R, Vizzardi E, Salvador L, Picichè M, Paparella D, Margari V, Troise G, Villa E, Dossena Y, Lucarelli C, Onorati F, Faggian G, Mariscalco G, Maselli D, Parolari A, and Lorusso R

Subjects
Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Italy, Male, Middle Aged, Registries, Time Factors, Tricuspid Valve Insufficiency complications, Tricuspid Valve Insufficiency surgery, Young Adult, Endocarditis surgery, Heart Valve Diseases microbiology, Heart Valve Diseases surgery, Tricuspid Valve surgery
Abstract

Background: To assess early and late mortality in patients with isolated acute tricuspid valve infective endocarditis (TVIE) using data from a multicenter registry., Methods: From 1983 to 2018, isolated acute TVIE was surgically treated in 157 (3.8%) patients [mean age 47 ± 16 years (range 15-86 years), 25% females]. Of these, 142 (90%) had native tricuspid regurgitation, 7 (5%) native tricuspid valve (TV) steno-regurgitation, and 8 (5%) prosthetic TVIE. Intravenous drug use (IVDU) was recorded in 38% of patients, infection involved cardiac implantable electronic device leads in 21%, and vascular catheters for dialysis in 1%; in the remaining cases, the cause was unknown. The primary endpoint was in-hospital outcome, long-term freedom from recurrence and overall survival., Results: Overall, 77 (49%) patients underwent TV repair, 72 (46%) TV replacement, and 8 (5%) prosthetic TV replacement. Early mortality was 11% (n = 17). Expected early mortality according to EndoSCORE was 12%, with age (odds ratio 1.06) and redo (odds ratio 6.64) as risk factors. Late deaths occurred in 31 patients and TVIE recurrences in 4. Survival rates at 10, 20, and 25 years were 66%, 60%, and 44%, respectively. Risk factors were age [hazard ratio (HR) 1.06], mycotic TVIE (HR 4.2), IVDU (HR 4.90), infected prosthesis replacement (HR 4.4), and presence of cardiac implantable electronic device leads (HR 3.0). No significant difference was found in valve repair vs. replacement and in IVDUs vs. non-IVDUs., Conclusions: Patients with isolated acute TVIE undergoing surgical treatment show acceptable early and late outcomes. TVIE recurrence was low, and repair of the affected valve does not seem to confer any advantage either at early or long term up to 25 years., (Copyright © 2019 Elsevier B.V. All rights reserved.)

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results